0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Clinical Evidence Synopsis | 
Mark D. Huffman, MD, MPH; Angharad N. de Cates, BMBCh, BA; Shah Ebrahim, DM
JAMA. 2014;312(19):2030-2031. doi:10.1001/jama.2014.13616.

Original Investigation |  FREE ONLINE FIRST
Joseph B. Muhlestein, MD; Donald L. Lappé, MD; Joao A. C. Lima, MD; et al.
JAMA. Published online November 17, 2014. doi:10.1001/jama.2014.15825
Includes: Supplemental Content

Medical News & Perspectives | 
Joan Stephenson, PhD
JAMA. 2014;312(11):1085. doi:10.1001/jama.2014.12696.

Global Health | 
M. J. Friedrich
JAMA. 2014;312(11):1088. doi:10.1001/jama.2014.12653.

Original Investigation | 
Michelle L. O’Donoghue, MD, MPH; Eugene Braunwald, MD; Harvey D. White, MBChB, DSc; et al.
JAMA. 2014;312(10):1006-1015. doi:10.1001/jama.2014.11061.
Includes: Supplemental Content

From the JAMA Network | 
Eric N. Prystowsky, MD; Edward T. Fry, MD
JAMA. 2014;312(10):1049-1050. doi:10.1001/jama.2014.5742.

Research Letter | 
D. Meeike Kusters, MD; Hans J. Avis, MD, PhD; Eric de Groot, MD, PhD; et al.
JAMA. 2014;312(10):1055-1057. doi:10.1001/jama.2014.8892.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;312(9):882. doi:10.1001/jama.2014.11282.

Editorial | 
Peter M. Nilsson, MD, PhD; Fredrik H. Nystrom, MD, PhD
JAMA. 2014;312(8):795-796. doi:10.1001/jama.2014.10058.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;312(8):839-840. doi:10.1001/jama.2014.9758.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Research Letter  | 
Eligibility for Statin Therapy According to New Cholesterol Guidelines and Prevalent Use of Medication to Lower Lipid Levels in an Older US Cohort:  The Atherosclerosis Risk in Communities Study Cohort
Michael D. Miedema, MD, MPH; Faye L. Lopez, MS, MPH; Michael J. Blaha, MD, MPH; et al.
JAMA Internal Medicine
Invited Commentary  | 
Learning to Act on Secondhand Tobacco Smoke Exposure to Limit Risk for Coronary Heart Disease
R. William Vandivier, MD
JAMA Internal Medicine
Research Letter  | 
Secondhand Tobacco Smoke Exposure Among Hospitalized Nonsmokers With Coronary Heart Disease
Sandra J. Japuntich, PhD; Michelle A. Eilers, BA; Sharon Shenhav, BA; et al.
JAMA Internal Medicine
Viewpoint  | 
Secondary Prevention of Cardiovascular Disease With Vorapaxar:  A New Era of 3-Drug Antiplatelet Therapy?
Mori J. Krantz, MD; Sanjay Kaul, MD